Based: Palo Alto, CA
Investors: Draper Fisher Jurvetson, ATA Ventures, Tako Ventures and Continental Properties
Scoop: Last summer, Theranos, which is looking to put together health IT systems that support more personalized medicine, raised $45 million in new equity and option financing in a deal that could ultimately be worth as much as $100 million. According to VentureBeat, the company's backers include Draper Fisher Jurvetson, ATA Ventures, Tako Ventures and Continental Properties. The company is pioneering the field of theranostics--the integration of technology with medical therapies to deliver the drug in the right dose at the correct time.